( MENAFN - EIN Presswire) The Interventional Cardiovascular Devices market is projected to expand at a CAGR of 4.66%, reaching a market size of USD 69.1 billion by 2032 ...

Bentley InnoMed GmbH announced the launch of the BeGraft stent graft system, an on-label bridging device for fenestrated ...

Christian Medical College inaugurates a state-of-the-art vascular surgery hybrid theatre, offering cutting-edge operations ...

Gore & Associates recently announced the first commercial use of the company’s Excluder conformable abdominal aortic ...

St. Luke's vascular surgeons were the first in the Northeast to enroll a patient in a research study that could revolutionize ...

Although neurointerventional technologies have advanced for aneurysms, current adjunctive devices such as stents and temporary balloons still present significant limitations. Balloons can provide a ...

With these added benefits, the Carrier Delivery Catheter may have novel applications such as post‐processing flow diverting stents that fail to maximally open during aneurysm embolizations. An ...

Meanwhile, Endospan has completed enrolment in the primary arm of a clinical trial evaluating its stent graft for the treatment of aortic arch disease. Give your business an edge with our leading ...

Figure 1 Posteroanterior and Lateral Films of the Chest, Demonstrating an Ascending Aortic Aneurysm, with Hyper-trophy of the Left Ventricle and Some Enlargement of the Left Atrium. On the 10th ...

Where do we stand on the technology available for surgical repair of aortic coarctation ... the current recommendation is primary stenting of the coarctation lesion. Currently, most of these ...